- Home
- HOWL vs EUDA Comparison
HOWL vs EUDA Comparison
Compare HOWL & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- EUDA
- Stock Information
- Founded
- HOWL 2017
- EUDA 2021
- Country
- HOWL United States
- EUDA Singapore
- Employees
- HOWL N/A
- EUDA N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- EUDA Blank Checks
- Sector
- HOWL Health Care
- EUDA Finance
- Exchange
- HOWL Nasdaq
- EUDA Nasdaq
- Market Cap
- HOWL 64.5M
- EUDA 68.7M
- IPO Year
- HOWL 2021
- EUDA N/A
- Fundamental
- Price
- HOWL $1.56
- EUDA $2.11
- Analyst Decision
- HOWL Strong Buy
- EUDA
- Analyst Count
- HOWL 5
- EUDA 0
- Target Price
- HOWL $7.20
- EUDA N/A
- AVG Volume (30 Days)
- HOWL 1.3M
- EUDA 90.9K
- Earning Date
- HOWL 11-14-2025
- EUDA 01-01-0001
- Dividend Yield
- HOWL N/A
- EUDA N/A
- EPS Growth
- HOWL N/A
- EUDA N/A
- EPS
- HOWL N/A
- EUDA 0.01
- Revenue
- HOWL N/A
- EUDA $5,160,280.00
- Revenue This Year
- HOWL N/A
- EUDA $137.25
- Revenue Next Year
- HOWL N/A
- EUDA $361.43
- P/E Ratio
- HOWL N/A
- EUDA $290.91
- Revenue Growth
- HOWL N/A
- EUDA 83.73
- 52 Week Low
- HOWL $0.60
- EUDA $1.03
- 52 Week High
- HOWL $2.96
- EUDA $6.30
- Technical
- Relative Strength Index (RSI)
- HOWL 45.71
- EUDA 43.41
- Support Level
- HOWL $1.55
- EUDA $1.79
- Resistance Level
- HOWL $1.83
- EUDA $2.66
- Average True Range (ATR)
- HOWL 0.13
- EUDA 0.51
- MACD
- HOWL -0.03
- EUDA -0.15
- Stochastic Oscillator
- HOWL 14.71
- EUDA 12.55
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.